We may have a COVID vaccine for children by September: ICMR-National Institute of Virology Director


NEW DELHI: The coronavirus vaccine for children may be available for use in September or October this year, informed Dr Priya Abraham, Director, ICMR-National Institute of Virology (NIV), Pune (Indian Council of Medical Research).

In an interview with an OTT channel of the Department of Science and Technology, Abraham said, “Phase 2 and 3 trials of Covaxin are underway for children between 2-18 years. Hopefully the results will be available soon, which Will be presented then. To regulators. So, by September or just after that, we can have vaccines for COVID-19 for children.”

In addition, he pointed out that in addition to Covaxin, Zydes Cadila is also undergoing trials for a vaccine for children. “The Zydus Cadila vaccine will be the first DNA vaccine available for use. Also, there is an m-RNA, Bio-E vaccine from Genoa Biopharmaceuticals Ltd., Novovax from Serum Institute and another interesting intranasal vaccine by Bharat Biotech, which does not require one. Can be given through the jab and nostrils,” said Abraham.

Earlier in an interview with ANI, AIIMS Director Dr Randeep Guleria on COVID-19 Vaccines for Children had said, “Vaccines for children in India should come out now as trials are already underway for available vaccines in the country. Bharat Biotech’s trials are in the final stages and we will have the data by September.”

Talking about how effective the COVID-19 vaccine is over the Delta Plus variant, Dr Priya Abraham said, “The Delta Plus variant is less likely to spread as compared to the Delta Plus variant, which is present in more than 130 countries. In NiV, we have studied antibodies produced in vaccinated people and thus tested against them. The efficacy of antibodies against delta is reduced by two-three times. Nevertheless, vaccines are protective against variants. Huh.”

Stating that the WHO has put a momentary moratorium on the booster dose of the COVID-19 vaccine, it said, “Studies (on the booster dose) are underway abroad. At least seven different vaccines are needed for the booster dose.” It has been tried. WHO has put it on hold until more countries are vaccinated, but booster dose recommendations will certainly come in the future.”

Recently, speaking about the booster dose, Dr Gagandeep Kang, Professor of Christine Medical College, Vellore, said on Tuesday that whether people will have more antibodies or will be better protected with a booster dose, it is still not known. Is.

Back to top button